» Articles » PMID: 36797360

Translating Transcriptomic Findings from Cancer Model Systems to Humans Through Joint Dimension Reduction

Overview
Journal Commun Biol
Specialty Biology
Date 2023 Feb 16
PMID 36797360
Authors
Affiliations
Soon will be listed here.
Abstract

Model systems are an essential resource in cancer research. They simulate effects that we can infer into humans, but come at a risk of inaccurately representing human biology. This inaccuracy can lead to inconclusive experiments or misleading results, urging the need for an improved process for translating model system findings into human-relevant data. We present a process for applying joint dimension reduction (jDR) to horizontally integrate gene expression data across model systems and human tumor cohorts. We then use this approach to combine human TCGA gene expression data with data from human cancer cell lines and mouse model tumors. By identifying the aspects of genomic variation joint-acting across cohorts, we demonstrate how predictive modeling and clinical biomarkers from model systems can be improved.

Citing Articles

Bridging systems biology and tissue engineering: Unleashing the full potential of complex 3D tissue models of disease.

Cadavid J, Li N, McGuigan A Biophys Rev (Melville). 2024; 5(2):021301.

PMID: 38617201 PMC: 11008916. DOI: 10.1063/5.0179125.


3D Cell Models in Radiobiology: Improving the Predictive Value of In Vitro Research.

Antonelli F Int J Mol Sci. 2023; 24(13).

PMID: 37445795 PMC: 10341460. DOI: 10.3390/ijms241310620.


An integrated model for predicting KRAS dependency.

Tsai Y, Chareddy Y, Price B, Parker J, Pecot C PLoS Comput Biol. 2023; 19(5):e1011095.

PMID: 37141389 PMC: 10187917. DOI: 10.1371/journal.pcbi.1011095.

References
1.
Mourragui S, Loog M, Vis D, Moore K, Manjon A, van de Wiel M . Predicting patient response with models trained on cell lines and patient-derived xenografts by nonlinear transfer learning. Proc Natl Acad Sci U S A. 2021; 118(49). PMC: 8670522. DOI: 10.1073/pnas.2106682118. View

2.
Tanioka M, Fan C, Parker J, Hoadley K, Hu Z, Li Y . Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer. Clin Cancer Res. 2018; 24(21):5292-5304. PMC: 6214737. DOI: 10.1158/1078-0432.CCR-17-3431. View

3.
Smith A, Walsh J, Long J, Davis C, Henstock P, Hodge M . Standard machine learning approaches outperform deep representation learning on phenotype prediction from transcriptomics data. BMC Bioinformatics. 2020; 21(1):119. PMC: 7085143. DOI: 10.1186/s12859-020-3427-8. View

4.
Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin A, Kim S . The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012; 483(7391):603-7. PMC: 3320027. DOI: 10.1038/nature11003. View

5.
Hollern D, Xu N, Thennavan A, Glodowski C, Garcia-Recio S, Mott K . B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer. Cell. 2019; 179(5):1191-1206.e21. PMC: 6911685. DOI: 10.1016/j.cell.2019.10.028. View